APOE and dementia: An early population-based, case-control study comparing the APOE allelic distribution of patients with stroke and concurrent dementia and age and ethnicity-matched controls with stroke but without dementia found that e4 homozygous individuals had a seven-fold increase in dementia risk and heterozygotes had a two-fold increased risk [76].